Physician
Major Medical LLC
Major Medical LLC was paid $3.02M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoMAJOR MEDICAL LLC
SILVER SPRING, MD 20910
SILVER SPRING, MD 20910
33aNPI1093039570assigned 03/26/2010
33bProvider typeFamily Medicine Physician
28Total paid$3.02M
24GClaims69,028
24DCodes billed59
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Maryland
Rank by total paid#13 of 287
Median peer was paid$78K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 657 | $42K | |
| 2019 | 807 | $35K | |
| 2020 | 9,988 | $417K | |
| 2021 | 23,627 | $953K | |
| 2022 | 19,173 | $784K | |
| 2023 | 12,550 | $591K | |
| 2024incomplete | 2,226 | $196K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 8,465 | 7,134 | $642K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 12% | 3,948 | 3,548 | $367K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.1% | 2,750 | 2,485 | $274K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 8.7% | 1,889 | 1,702 | $262K |
| 86769 | 5.1% | 4,475 | 2,112 | $153K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.3% | 361 | 313 | $131K |
| 87481 | 3.3% | 1,106 | 1,028 | $99K | |
| 87581 | 3.0% | 2,896 | 2,579 | $91K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.8% | 720 | 703 | $85K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.8% | 676 | 657 | $84K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 1,100 | 1,037 | $57K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.6% | 1,761 | 1,692 | $50K |
47 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 3,081 | $48K |
| 80061 | Lipid panel | 1.5% | 3,548 | $44K |
| 84481 | 1.4% | 2,729 | $43K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 1,287 | $42K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 1,286 | $42K |
| 84403 | 1.3% | 1,708 | $40K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 1,173 | $39K |
| 87500 | 1.2% | 1,070 | $36K | |
| 87641 | 1.2% | 1,071 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 704 | $35K |
| 80053 | Comprehensive metabolic panel | 1.1% | 3,418 | $33K |
| 82670 | <1% | 925 | $24K | |
| 83970 | <1% | 575 | $23K | |
| 84439 | <1% | 2,735 | $23K | |
| 82607 | <1% | 1,316 | $19K | |
| 83002 | <1% | 1,029 | $18K | |
| 82746 | <1% | 1,220 | $17K | |
| 82533 | <1% | 1,057 | $16K | |
| 83540 | <1% | 2,537 | $15K | |
| 83001 | <1% | 739 | $13K | |
| 84154 | <1% | 775 | $13K | |
| 84153 | <1% | 752 | $12K | |
| 82728 | <1% | 919 | $12K | |
| 84144 | <1% | 557 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 65 | $10K |
| 84146 | <1% | 559 | $10K | |
| 84270 | <1% | 284 | $6K | |
| 87507 | <1% | 16 | $6K | |
| 99385 | <1% | 41 | $6K | |
| 82677 | <1% | 407 | $5K | |
| 82627 | <1% | 200 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 37 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 381 | $3K |
| 87650 | <1% | 126 | $2K | |
| 87653 | <1% | 59 | $2K | |
| 0011A | <1% | 39 | $1K | |
| 93000 | <1% | 93 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 30 | $1K |
| 93922 | <1% | 12 | $953.99 | |
| 87529 | <1% | 41 | $811.63 | |
| 87631 | <1% | 38 | $806.60 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 18 | $792.24 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 82 | $727.57 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 57 | $655.56 |
| 99442 | <1% | 59 | $622.30 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 14 | $587.60 |
| 99441 | <1% | 12 | $74.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAJOR, MARK (DOCTOR/OWNER)